ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.04159
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,624.09
0.21%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Lannett Company Inc (LCI)

  7. Lannett Company Inc (LCI) Noticias

LCI

Lannett (LCI)

Lannett Company Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:LCI
FechaHoraFuenteTítuloSímboloCompañía
26/06/202305:03Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:LCILannett Company Inc
20/06/202305:53Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NYSE:LCILannett Company Inc
20/06/202305:52Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:LCILannett Company Inc
20/06/202305:48Edgar (US Regulatory)Current Report Filing (8-k)NYSE:LCILannett Company Inc
15/05/202315:32Edgar (US Regulatory)Quarterly Report (10-q)NYSE:LCILannett Company Inc
04/05/202309:20Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:LCILannett Company Inc
01/05/202305:55PR Newswire (US)Lannett Company, Inc. Enters Into Restructuring Support AgreementNYSE:LCILannett Company Inc
20/04/202305:53PR Newswire (US)NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSNYSE:LCILannett Company Inc
04/04/202305:55PR Newswire (US)LANNETT SHARES UPDATENYSE:LCILannett Company Inc
10/02/202308:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:LCILannett Company Inc
01/02/202315:15PR Newswire (US)LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCENYSE:LCILannett Company Inc
25/01/202315:30PR Newswire (US)LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITNYSE:LCILannett Company Inc
25/01/202305:52PR Newswire (US)LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1NYSE:LCILannett Company Inc
04/01/202305:52PR Newswire (US)LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTSNYSE:LCILannett Company Inc
18/11/202215:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:LCILannett Company Inc
10/11/202215:14Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:LCILannett Company Inc
07/11/202205:52PR Newswire (US)LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAMNYSE:LCILannett Company Inc
02/11/202215:15PR Newswire (US)LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCENYSE:LCILannett Company Inc
26/10/202205:52PR Newswire (US)LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2NYSE:LCILannett Company Inc
21/10/202205:53PR Newswire (US)LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANTNYSE:LCILannett Company Inc
19/10/202205:55PR Newswire (US)LANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGSNYSE:LCILannett Company Inc
31/08/202205:53PR Newswire (US)LANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINENYSE:LCILannett Company Inc
25/08/202207:11Edgar (US Regulatory)Annual Report (10-k)NYSE:LCILannett Company Inc
24/08/202215:15PR Newswire (US)LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTSNYSE:LCILannett Company Inc
19/08/202205:52PR Newswire (US)LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24NYSE:LCILannett Company Inc
01/06/202205:52PR Newswire (US)LANNETT PROVIDES UPDATE ON PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINENYSE:LCILannett Company Inc
12/05/202205:52PR Newswire (US)LANNETT ENTERS AGREEMENT TO BE EXCLUSIVE U.S. DISTRIBUTOR OF FLUDARABINE PHOSPATE FOR INJECTION, USPNYSE:LCILannett Company Inc
04/05/202215:15PR Newswire (US)LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTSNYSE:LCILannett Company Inc
27/04/202205:52PR Newswire (US)LANNETT TO REPORT FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, MAY 4NYSE:LCILannett Company Inc
29/03/202205:52PR Newswire (US)LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINENYSE:LCILannett Company Inc
 Showing the most relevant articles for your search:NYSE:LCI

Su Consulta Reciente

BIT
P1XXR9
NLBNPIT1XXR9 20240621 240
BIT
UB2623
UniCredit Bank
BIT
I04929
Banca IMI
BIT
P202U5
NLBNPIT202U5 20241220 130
BIT
P1W5X6
NLBNPIT1W5X6 20351221 82...
BIT
P1Y9W8
NLBNPIT1Y9W8 20240621 42
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados